BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nagy G, Szekely TE, Somogyi A, Herold M, Herold Z. New therapeutic approaches for type 1 diabetes: Disease-modifying therapies. World J Diabetes 2022; 13(10): 835-850 [PMID: 36312000 DOI: 10.4239/wjd.v13.i10.835]
URL: https://www.wjgnet.com/1007-9327/full/v13/i10/835.htm
Number Citing Articles
1
Jason Seewoodhary, Angela Silveira. Teplizumab – preventative approaches to type 1 diabetes mellitusPractical Diabetes 2023; 40(2): 35 doi: 10.1002/pdi.2448
2
Diletta Maria Francesca Ingrosso, Maria Teresa Quarta, Alessia Quarta, Francesco Chiarelli. Prevention of Type 1 Diabetes in Children: A Worthy Challenge?International Journal of Environmental Research and Public Health 2023; 20(11): 5962 doi: 10.3390/ijerph20115962
3
Rossana Caldara, Valentina Tomajer, Paolo Monti, Valeria Sordi, Antonio Citro, Raniero Chimienti, Chiara Gremizzi, Davide Catarinella, Stefano Tentori, Vera Paloschi, Raffella Melzi, Alessia Mercalli, Rita Nano, Paola Magistretti, Stefano Partelli, Lorenzo Piemonti. Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challengeFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1323439
4
Mingshu Huang, Weixing Chen, Min Wang, Yisheng Huang, Hongyu Liu, Yue Ming, Yuanxin Chen, Zhengming Tang, Bo Jia. Advanced Delivery Strategies for Immunotherapy in Type I Diabetes MellitusBioDrugs 2023; 37(3): 331 doi: 10.1007/s40259-023-00594-6
5
Yu.V. Bykov. Prevention of type 1 diabetes mellitus in children and adolescentsProfilakticheskaya meditsina 2024; 27(1): 115 doi: 10.17116/profmed202427011115